GoodSense Eye Drops 0.5oz, Advanced 19, 2019

Manufacturer
Geiss, Destin & Dunn, Inc.
Effective date
2019-12-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:55:32

Label at a glance#

ProductGoodSense Advanced Relief Eye
Active ingredientDEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE
Label structure13 sections

Storage and handling

Other information store at 15° to 25°C (59° to 77°F)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients                                             Purpose

Dextran 70 0.1%..............................................Lubricant

Polyethylene glycrol 400 1%..............................Lubricant

Povidone 1%....................................................Lubricant

Tetrahydrozoline HCI 0.05%..............................Redness reliever

OTC - PURPOSE SECTION

Uses

  • for the relief of redness of the eye due to minor eye irritations
  • for use as a protectant against further irritation or to relieve dryness of the eye

WARNINGS SECTION

Warnings

For external use only

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have narrow angle glaucoma.

OTC - WHEN USING SECTION

When using this product

  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using
  • do not use if this solution changes color or becomes cloudy
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Directions

  • to open bottle, push cap down and twist counter-clockwise. To close bottle, twist clockwise until it stops turning.
  • put 1 to 2 drops in the affected eye(s) up to 4 times daily
  • children under 6 years of age: ask a doctor

STORAGE AND HANDLING SECTION

Other information

  • store at 15° to 25°C (59° to 77°F)

INACTIVE INGREDIENT SECTION

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium chloride

DOSAGE & ADMINISTRATION SECTION

Distributed by:

Geiss, Destin & Dunn, Inc.

Peachtree, City GA 30269

www.valuelabels.com

1-866-696-0957

Made in Korea

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50804-019-052023-08-11C16284748780-1d6a99b39-8575-a426-e053-dadaa90af4c2GoodSense Eye Drops 0.5oz, Advanced 19, 2019
50804-019-052022-01-28C16284748780-1d6a99b39-8575-a426-e053-dadaa90af4c2GoodSense Eye Drops 0.5oz, Advanced 19, 2019

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50804-01950804-019-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
02ad6800-57fe-171f-e063-6294a90a7833ada3a039-78ba-4f11-9291-9385d028c5772023-08-11WarningsExact identifier
spl set id: ada3a039-78ba-4f11-9291-9385d028c577

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.